Anthracycline based chemotherapies could have greater negative effects on cognition than nonanthracycline treatments for breast cancer survivors, a new study reports.
Patients who experience chemobrain after treatment for cancer show brain network disruptions, researchers report.
Researchers report our gender can determine longevity and response to treatment for glioblastoma brain cancer. The study reports male survival is determined by genes that control cell division, where as female survival is often determine by genes that regulate the ability of cancer cells to migrate to different brain areas.
Manipulating gut bacteria in mice before chemotherapy reduces the mental fog of "chemo brain."
Researchers use focused ultrasound to safely and non-invasively open the blood-brain barrier in Alzheimer's patients.
Researchers gain inspiration for creating tiny artificial brains, that can be used for cancer research, from an ancient Japanese art of flower arranging.
A newly developed ion pump can deliver cancer-fighting drugs more accurately, and with fewer side effects than conventional chemotherapy, to those with glioblastoma brain cancer.
Researchers report children who received chemotherapy alone for acute lymphoblastic leukemia remain at risk for attention and learning problems after the treatment ends.
Researchers suggest delivering chemotherapy directly into the brain cavity could offer a better way to treat tumors which have metastasized to the brain.
An inhibitor of the 20-HETE chemical has been used to successfully control the spread and growth of human glioblastoma and breast cancer in lab models of the diseases, researchers report.
Researchers have successfully used focused ultrasound to non-invasively penetrate the blood-brain barrier and deliver chemotherapy to a patient with brain cancer.
Brain cancer cells resist therapy by temporarily losing gene mutations targeted by drugs, but re-amplify the mutation once the treatments have stopped, a new study reports.
